Cobas 6800 reagents option period 2
Active Awarded Last action
- Contract number
- 36C24826N0207
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
Veterans Integrated Service Network 8
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $290,700
Award facts
- Contract value 13% obligated
-
- $1,166,320.30 Current, with exercised options
- $2,192,254.20 Potential, with all options
- Completion date 24% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Castleton, IN 46256, USA
Award details come from SAM.gov/FPDS.
About this award
Roche Diagnostics Corporation has been awarded a Firm Fixed Price Blanket Purchase Agreement (BPA) call valued at $2.19 million for COBAS 6800 reagents under Option Period 2. The award, issued February 1, 2026, with completion scheduled for January 31, 2029, is funded by Veterans Integrated Service Network 8 (VISN 8), a component of the Department of Veterans Affairs. This contract is a child award under the General Services Administration's Critical Analyzers, Laboratory (FSS-66-III) master schedule and does not utilize a set-aside designation. The reagents will support the COBAS 6800 automated laboratory analyzer system, a molecular and clinical chemistry platform widely used across VA healthcare facilities for diagnostic testing.
Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostic equipment and reagents, holds multiple significant contracts across federal healthcare agencies. As a global leader in diagnostic solutions, the company provides comprehensive laboratory testing systems and specialized reagents to support medical research and patient care throughout the VA system and other federal agencies. The work will be performed in Castleton, Indiana, and represents part of Roche's broader portfolio of COBAS system supply contracts across multiple VISN regions, enabling VA healthcare facilities to maintain critical diagnostic capabilities through pre-negotiated pricing and streamlined procurement mechanisms.
Quick answers
Who was awarded contract 36C24826N0207?
36C24826N0207 was awarded to Roche Diagnostics Corporation by Veterans Integrated Service Network 8 (Veterans Health Administration) on February 1, 2026.
How much is contract 36C24826N0207 worth?
The government has obligated $290,700 on 36C24826N0207. Its current value, with exercised options, is $1,166,320. Its potential value, with all options, is $2,192,254.
Is contract 36C24826N0207 an order under another contract?
Yes. 36C24826N0207 is a BPA call under V797D70105-36C24824A0011, a blanket purchase agreement, on Critical Analyzers, Laboratory (FSS-66-III).
Was contract 36C24826N0207 competed?
The extent of competition for 36C24826N0207 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award